Skip to main content

Publications

featured publications

  • Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.

    Lancet (London, England)

    Authors: Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack, Joachim Peter Steinbach, Uwe Schlegel, Michael Sabel, Peter Hau, Rolf-Dieter Kortmann, Dietmar Krex, Oliver Grauer, Roland Goldbrunner, Oliver Schnell, Oliver Bähr, Martin Uhl, Clemens Seidel, Ghazaleh Tabatabai, Thomas Kowalski, Florian Ringel, Friederike Schmidt-Graf, Bogdana Suchorska, Stefanie Brehmer, Astrid Weyerbrock, Miriam Renovanz, Lars Bullinger, Norbert Galldiks, Peter Vajkoczy, Martin Misch, Hartmut Vatter, Moritz Stuplich, Niklas Schäfer, Sied Kebir, Johannes Weller, Christina Schaub, Walter Stummer, Jörg-Christian Tonn, Matthias Simon, Vera C Keil, Michael Nelles, Horst Urbach, Martin Coenen, Wolfgang Wick, Michael Weller, Rolf Fimmers, Matthias Schmid, Elke Hattingen, Torsten Pietsch, Christoph Coch, Martin Glas

  • Drug-induced anaphylactic reactions in children: A retrospective analysis of 159 validated spontaneous reports.

    Pharmacoepidemiology and drug safety

    Authors: Bernhardt Sachs, Diana Dubrall, Wilma Fischer-Barth, Matthias Schmid, Julia Stingl

  • Developmental trajectories of body mass index from childhood into late adolescence and subsequent late adolescence-young adulthood cardiometabolic risk markers.

    Cardiovascular diabetology

    Authors: Kolade Oluwagbemigun, Anette E Buyken, Ute Alexy, Matthias Schmid, Christian Herder, Ute Nöthlings

  • Addendum to: Approaches to Regularized Regression - A Comparison between Gradient Boosting and the Lasso.

    Methods of information in medicine

    Authors: Tobias Hepp, Matthias Schmid, Olaf Gefeller, Elisabeth Waldmann, Andreas Mayr